SCHEMBL24448919

SCHEMBL24448919

O=c1nc(Cl)c2cc(Cl)c(Br)cc2n1-c1ccccc1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.39
▸ MGLL Q99685 1/20 0.38
▸ MAPK14 Q16539 1/20 0.36
▸ MAT2A P31153 8/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ PRMT5 O14744 1/20 0.33
▸ TDO2 P48775 3/20 0.33
▸ IDO2 Q6ZQW0 3/20 0.33
▸ IDO1 P14902 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ MAPK8 P45983 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30170705 0.80 KRAS (0.45) MGLLMAT2AKRAS
SCHEMBL23735736 0.77 KRAS (0.37) MAT2APRMT5KRAS
SCHEMBL22093081 0.71 MAT2A (0.54) MAT2A
SCHEMBL29571124 0.71 MAT2A (0.54) MAT2A
SCHEMBL30499848 0.71 PTGES (0.43) MAT2AALDH1A1
SCHEMBL22093070 0.66 MAT2A (0.54) MAT2AALDH1A1LMNA
SCHEMBL29284828 0.66 ALDH1A1 (0.44) MAPK14ALDH1A1HSD17B10LMNAMAPT
SCHEMBL31145385 0.65 MAT2A (0.41) MAT2A
SCHEMBL22093080 0.63 ADORA3 (0.42) MGLLMAT2AALDH1A1HTTLMNA
SCHEMBL31145394 0.63 ADORA3 (0.42) MGLLMAT2AALDH1A1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4001269-A1 BENZOISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER Amgen Inc. (US) 2022-05-25 — — EP disclosed
Send feedback